News
As rumors swirl around Legendary's reported interest in acquiring Lionsgate, studios and film libraries are still attracting ...
SOBE Thermal Energy Systems LLC, the company seeking to convert rubber tire chips into synthetic gas at its Youngstown facility, lost a $468,000 lawsuit for failing to pay for equipment and is facing ...
LENSAR and Alcon's deal presents upside and uncertainty, LENSAR for speculators, Alcon for stability. Check out more on LNSR ...
Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Strategy” second quarter 2025 ...
2d
Sportschosun on MSNOver 70% of digital eye fatigue with half a day of overwork...Conduct a regular eye break digital br...As of 2024 data, it is estimated that more than 1.6 billion people worldwide suffer from dry eye symptoms, and the number of ...
Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference - Avant Technologies, Inc. ("Avant" or the "Company"), an emerging technology company developing healthcare solutions ...
Madison Investments, an investment advisor, released its “Madison Large Cap Fund” second-quarter 2025 investor letter. A copy ...
While Bronny James and other young talent were lighting up the NBA Summer League court in Las Vegas, another game was being ...
Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...
Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
Alcon AG plans to acquire Lumithera Inc., adding its photobiomodulation (PBM) device designed to treat early and intermediate dry age-related macular degeneration (AMD) to the Alcon portfolio. The ...
Monday announced its intention to acquire LumiThera and its PBM device for the treatment of early and intermediate dry AMD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results